| Document |
Document Title |
|
WO/2021/000247A1 |
Disclosed are a strain for producing nattokinase and a production method therefor. In particular, the present invention involves a new strain capable of producing nattokinase, i.e. Bacillus subtilis natto ST-1086, deposited at the China ...
|
|
WO/2021/000637A1 |
Provided are a daptomycin-producing Streptomyces griseus L340 strain and application thereof, the accession number of the strain being CGMCC 17921. The L340 strain has relatively stable genetic characteristics and fermentation units, and...
|
|
WO/2021/001368A1 |
Use of a fructose disaccharide or fructooligosaccharide, for increasing protein production in Bifidobacterium longum subsp longum.
|
|
WO/2021/000246A1 |
Provided is a Bacillus subtilis natto ST-1008, deposited under the accession number CGMCC No. 17894. Also provided is a method for producing MK-7. The method comprises: culturing the Bacillus subtilis natto of CGMCC No. 17894 in a cultur...
|
|
WO/2021/001840A1 |
A recombinant bacterium having the ability to/express MaSP-based proteins, nucleic acids encoding same and method for the preparation of synthetic dragline spider silk are provided.
|
|
WO/2020/261055A1 |
The present invention relates to the strain of Lactobacillus plantarum NCIMB 43029, the strain of Lactobacillus acidophilus NCIMB 43030, a composition with both antibacterial and re- epithelializing action which includes Lactobacillus pl...
|
|
WO/2020/258110A1 |
Provided are a recombinant NAD synthetase and a gene and use thereof. Said enzyme comprises a nicotinamide mononucleotide adenosyltransferase domain from Haemophilus influenzae and a nicotinamide ribokinase domain from any one of human, ...
|
|
WO/2020/263734A1 |
The present disclosure provides fungicidal Erwinia and Pseudomonas strains useful for protecting plants and enhancing crop yield, as well as cultures and inoculant compositions comprising the isolated strains, cellular extracts derived f...
|
|
WO/2020/261289A1 |
The molecular weight of hyaluronic acid (HA) is a critical property which determines its usage in various biomedical applications. The invention pertains to a process for production of higher MWHA (3.4 MDa) throughout the fermentation ti...
|
|
WO/2020/258757A1 |
Provided are a mutant strain of type 3 duck hepatovirus CH-P60-117C strain and a construction method therefor. Specifically, the nucleotide at position 117 of the genome 5'UTR of type 3 virulent duck hepatovirus strain is mutated from A ...
|
|
WO/2020/262910A1 |
The purpose of the present invention is to provide: a composition for preventing plant diseases, containing, as an active ingredient, any one or more selected from the group consisting of a Brevibacillus brevis strain HK544, a culture me...
|
|
WO/2020/264258A1 |
The disclosure relates to a sarcoidosis animal model and methods of inducing sarcoidosis in an animal. The disclosure also related to methods of producing an in vitro granuloma, and methods of using the sarcoidosis animal model. Disclose...
|
|
WO/2020/259585A1 |
An engineered bacterium for producing hydroxytyrosol and a method for producing hydroxytyrosol by using the engineered bacterium. By using the engineered bacterium to catalyze tyrosine to produce hydroxytyrosol by means of a dual path, a...
|
|
WO/2020/258896A1 |
Provided are a strain and method for producing rosmarinic acid. Recombinant cells expressing 4-coumarate-CoA ligase, rosmarinic acid synthase, polyphosphate kinase 2-I, and polyphosphate kinase 2-II or combinations of the recombinant cel...
|
|
WO/2020/263720A1 |
Described are strains and methods relating to genetically-engineered yeast cells that overproduce lysine in a tunable manner by altering feedback inhibition of the lysine synthetic pathway by way of the LYS20 and LYS21 homocitrate syntha...
|
|
WO/2020/257987A1 |
Provided are SNP markers of drug reduced susceptibility related evolutionary branches of Clostridium difficile, a method for identifying the category of a Clostridium difficile strain, and use thereof. The SNP markers are specific marker...
|
|
WO/2020/259569A1 |
Provided is an approach using an engineered strain for producing hydroxytyrosol. The engineered strain simultaneously expresses a hydroxylase that catalyzes the conversion of tyrosol into hydroxytyrosol, and an enzyme that catalyzes the ...
|
|
WO/2020/257769A1 |
The present invention provides Bacillus isolates, as well as probiotic and animal feed compositions comprising said isolates, which may be included in the diet of poultry to improve growth performance with reduced energy diets. Methods o...
|
|
WO/2020/254604A1 |
A method for producing a fermented milk product (e.g. a yogurt) with a relatively high stable pH value at the end of the fermentation comprising inoculating milk with Streptococcus thermophilus (ST) Gal(+) bacteria.
|
|
WO/2020/252826A1 |
Provided are a fusion albumin nanoparticle and a preparation method therefor. The invention utilizes genetic engineering to express a fusion albumin, and employs self-assembly in a neutral aqueous solution to load a drug. The fusion albu...
|
|
WO/2020/256434A1 |
The present invention provides a streptomyces sp. SNC087 strain (KCCM12505P) that is isolated from seawater and produces staurosporine, a method for producing staurosporine using same, a method for culturing same, and a pure culture medi...
|
|
WO/2020/219893A3 |
The present disclosure provides high-throughput methods for rapidly mutagenizing, screening, and targeting candidate microbes that are capable of fixing atmospheric nitrogen in the presence of exogenous nitrogen. The methods utilize a mi...
|
|
WO/2020/254533A1 |
The present invention relates to a novel biocontrol agent and to the use thereof for controlling fungal diseases of plants.
|
|
WO/2020/248359A1 |
The present invention relates to a recombinant bacterium with high production of hyaluronic acid, a construction method and an application thereof in the technical field of genetic engineering. The recombinant bacterium is constructed by...
|
|
WO/2020/251113A1 |
The present invention relates to a novel Geobacillus sp. strain and a use thereof, and more specifically, to: a novel Geobacillus sp. strain isolated from soil and having very excellent organic waste decomposing activity; and a use there...
|
|
WO/2020/252462A1 |
The present invention relates to methods and compositions for the treatment of nontuberculous mycobacterium (NTM) infection including administering to the patient one or more antibiotics (such as an aminoglycoside antibiotic), and admini...
|
|
WO/2020/251290A1 |
The present invention relates to a Wickerhamomyces ciferrii mutant strain overproducing tetraacetylphytosphingosine (TAPS) and a TAPS production method using same. The Wickerhamomyces ciferrii mutant strain, provided in the present inven...
|
|
WO/2020/249811A1 |
The invention provides a B. thuringiensis{Bt) strain which does not produce beta-exotoxin and which exhibits insecticidal activity against Spodoptera frugiperda, an insect whose control is poor or ineffective with the currently market av...
|
|
WO/2020/248962A1 |
Provided are a high-temperature sensitive Saccharomyces cerevisiae and application thereof. Through the mutagenesis of Saccharomyces pastorianus Pilsner with ARTP and making use of the principle that blue precipitate can be generated fro...
|
|
WO/2020/159298A3 |
The present invention relates to novel microalgae having high loliolide productivity. Scenedesmus sp. HS4 of the present invention has high biomass productivity and high loliolide content, thereby being usable as a biological resource ca...
|
|
WO/2020/244527A1 |
Provided is a recombinant Bacillus subtilis capable of increasing the yield of menaquinone-7, characterized by using Bacillus subtilis 168 as a starting strain, and replacing natural promoters of menaquinone isochorismate synthase gene m...
|
|
WO/2020/245216A1 |
The present invention relates to the Lactobacillus paracasei strain deposited at the CNCM under reference number CNCM I-5369 The present invention also relates to a mixture of the peptides having the following sequences: (SEQ ID NO 1), (...
|
|
WO/2020/245675A1 |
The present invention relates to the agronomic field. Specifically, it relates to a Methylobacterium sp. nov. strain, deposited under accession number CECT 9580, to compositions comprising it, and to its use as bio-stimulant and endophyt...
|
|
WO/2020/076136A9 |
The present invention relates to a Akkermansia muciniphila SNUG-61027 strain (accession number KCTC 13530BP) and a use thereof. Specifically provided are: a composition for appetite control or prevention, improvement, alleviation or trea...
|
|
WO/2020/244380A1 |
Provided is a means of knocking out the glnR gene by means of homologous recombination, and a method and application thereof for obtaining a Lactobacillus brevis glnR knockout strain to improve the ability of Lactobacillus brevis γ-amin...
|
|
WO/2020/237817A1 |
Provided is a new type of Vibrio parahaemolyticus Serotype K (capsular antigen) and an application thereof. The preservation number of Vibrio parahaemolyticus is CGMCC No.17249 in the General Microbiology Center of China Microbial Cultur...
|
|
WO/2020/238010A1 |
Provided is a method for producing OPO using microbial fermentation. The method comprises the following steps: inoculating an activation medium with a microorganism, and carrying out shaker culturing to obtain an activated strain; adding...
|
|
WO/2020/239040A1 |
Provided are a recombinant oncolytic virus, a preparation method therefor, the use thereof and a medicine thereof, wherein the genome sequence of the recombinant oncolytic virus includes the following exogenous elements: (1) a first expr...
|
|
WO/2020/240574A1 |
Nowadays consumers are looking for "natural" food ingredients for keeping them healthy and fit in all foods. "An Organic Natural Microbial Inhibitor" is an organic antimicrobial ingredient that is synthesized from the fermentation of nat...
|
|
WO/2020/238870A1 |
Provided are Pediococcus acidilactici CCFM6432 capable of relieving depression, fermented food thereof, and application thereof. Pediococcus acidilactici CCFM6432 can be used to prepare foods, healthcare products, and drugs having anti-d...
|
|
WO/2020/239064A1 |
Provided is a thermostable glucose oxidase obtained by introducing at least one pair of disulfide bonds into the amino acid sequence of a wild-type Aspergillus niger glucose oxidase or a mutant Aspergillus niger glucose oxidase. The gluc...
|
|
WO/2020/237701A1 |
Provided are a high-yield L-histidine genetically engineered bacterium strain, and a construction method therefor and an application thereof, integrating a corynebacterium glutamicum ATP phosphoribosyl transferase HisG mutant encoding ge...
|
|
WO/2020/239936A1 |
Present invention relates to new strains of Bacillus paralicheniformis with improved ability to form biofilm and colonize the rhizosphere when compared to their parental strains from where they are derived.
|
|
WO/2020/233102A1 |
Provided are a pharmaceutical composition for treatment of a tumor or cancer, and an application thereof. The pharmaceutical composition comprises an oncolytic rhabdovirus and a CD38 small molecule inhibitor such as rhein by means of dir...
|
|
WO/2020/234760A1 |
The present invention relates to a bacterial strain selected for production of enzymes with high dehairing capacity. It further relates to a supernatant obtained from said bacterial strain and a method that comprises the use of said supe...
|
|
WO/2020/232519A1 |
The present invention describes the composition of an animal feed additive containing a nutrient-rich fermented broth obtained by means of a fermentation process using a genetically modified microorganism. The non-pathogenic bacterium Co...
|
|
WO/2020/233147A1 |
Disclosed are an inert carrier Escherichia coli and the use thereof, wherein the inert carrier Escherichia coli has been deposited in the China General Microbiological Culture Collection Center (CGMCC), with a deposit address of Beijing,...
|
|
WO/2020/232734A1 |
Provided is a method for causing a non-toxic microalgae to produce a microcystin, and a microalgae, obtained by means of said method, which can produce a microcystin. The method uses a biosynthetic method to begin synthesis of microcysti...
|
|
WO/2020/233506A1 |
A method for improving the production of streptomyces polyketide compounds is provided. The method greatly improves the capability of the streptomyces polyketide compounds by strengthening a triacylglycerol decomposition pathway in strep...
|
|
WO/2020/233148A1 |
Provided is an inert carrier Salmonella sp. S9 and an application thereof. The deposit number of the inert carrier Salmonella sp. is CGMCC No.17340, and the deposit date is March 18, 2019. The Salmonella sp. has no macroscopic agglutinat...
|
